Ståle H. Nymo

2.0k total citations
31 papers, 1.3k citations indexed

About

Ståle H. Nymo is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Ståle H. Nymo has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Ståle H. Nymo's work include Cardiac Fibrosis and Remodeling (7 papers), Signaling Pathways in Disease (4 papers) and Peptidase Inhibition and Analysis (4 papers). Ståle H. Nymo is often cited by papers focused on Cardiac Fibrosis and Remodeling (7 papers), Signaling Pathways in Disease (4 papers) and Peptidase Inhibition and Analysis (4 papers). Ståle H. Nymo collaborates with scholars based in Norway, United Kingdom and Sweden. Ståle H. Nymo's co-authors include Thor Ueland, Pål Aukrust, Lars Gullestad, John J.V. McMurray, Arne Yndestad, John Kjekshus, Erik T. Askevold, John Wikstrand, Pieter Muntendam and John G.F. Cleland and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Ståle H. Nymo

31 papers receiving 1.2k citations

Peers

Ståle H. Nymo
Navin Suthahar Netherlands
Cory R. Trankle United States
A Blann United Kingdom
Aaron W. Aday United States
Navin Suthahar Netherlands
Ståle H. Nymo
Citations per year, relative to Ståle H. Nymo Ståle H. Nymo (= 1×) peers Navin Suthahar

Countries citing papers authored by Ståle H. Nymo

Since Specialization
Citations

This map shows the geographic impact of Ståle H. Nymo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ståle H. Nymo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ståle H. Nymo more than expected).

Fields of papers citing papers by Ståle H. Nymo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ståle H. Nymo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ståle H. Nymo. The network helps show where Ståle H. Nymo may publish in the future.

Co-authorship network of co-authors of Ståle H. Nymo

This figure shows the co-authorship network connecting the top 25 collaborators of Ståle H. Nymo. A scholar is included among the top collaborators of Ståle H. Nymo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ståle H. Nymo. Ståle H. Nymo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nymo, Stig, et al.. (2025). Unplanned transfers from wards to intensive care units: how well does NEWS identify patients in need of urgent escalation of care?. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 33(1). 105–105. 1 indexed citations
3.
Nymo, Ståle H., et al.. (2019). Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation—A single-blinded, randomized clinical trial. American Heart Journal. 221. 114–124. 10 indexed citations
4.
Holter, Jan Cato, Annika E. Michelsen, Ståle H. Nymo, et al.. (2019). Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study. ERJ Open Research. 5(1). 14–2019. 26 indexed citations
5.
Colas, Romain A., Anne Kristine Anstensrud, Ida Gregersen, et al.. (2019). Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction. EBioMedicine. 46. 264–273. 30 indexed citations
6.
Emdin, Michele, Alberto Aimo, Giuseppe Vergaro, et al.. (2018). sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T. Journal of the American College of Cardiology. 72(19). 2309–2320. 130 indexed citations
7.
Nymo, Ståle H., Marianne Hartford, Thor Ueland, et al.. (2018). Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome. International Journal of Cardiology. 262. 79–84. 14 indexed citations
8.
Nymo, Ståle H., Pål Aukrust, John Kjekshus, et al.. (2017). Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure. JACC Heart Failure. 5(4). 256–264. 25 indexed citations
9.
Dahl, Christen P., Ivar Risnes, Pavol Bohov, et al.. (2015). Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure. Journal of Cardiac Failure. 21(11). 916–923. 24 indexed citations
10.
Askevold, Erik T., Lars Gullestad, Ståle H. Nymo, et al.. (2015). Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). PLoS ONE. 10(8). e0133970–e0133970. 24 indexed citations
11.
Sandanger, Øystein, Erhe Gao, Trine Ranheim, et al.. (2015). NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective. Biochemical and Biophysical Research Communications. 469(4). 1012–1020. 88 indexed citations
12.
Ueland, Thor, Pål Aukrust, Ståle H. Nymo, et al.. (2014). Novel Extracellular Matrix Biomarkers as Predictors of Adverse Outcome in Chronic Heart Failure: Association Between Biglycan and Response to Statin Therapy in the CORONA Trial. Journal of Cardiac Failure. 21(2). 153–159. 10 indexed citations
13.
Ueland, Thor, Ståle H. Nymo, Roberto Latini, et al.. (2013). CCL21 is Associated with Fatal Outcomes in Chronic Heart Failure: Data from CORONA and GISSI-HF Trials. European Journal of Heart Failure. 15(7). 747–755. 15 indexed citations
14.
Nymo, Ståle H., Johannes Hulthe, Thor Ueland, et al.. (2013). Inflammatory Cytokines in Chronic Heart Failure: Interleukin-8 is Associated with Adverse Outcome. Results from CORONA. European Journal of Heart Failure. 16(1). 68–75. 64 indexed citations
15.
Broch, Kaspar, Thor Ueland, Ståle H. Nymo, et al.. (2012). Soluble ST2 is Associated with Adverse Outcome in Patients with Heart Failure of Ischaemic Aetiology. European Journal of Heart Failure. 14(3). 268–277. 106 indexed citations
16.
Latini, Roberto, Lars Gullestad, Serge Masson, et al.. (2012). Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF Trials. European Journal of Heart Failure. 14(9). 992–999. 80 indexed citations
17.
Gullestad, Lars, Thor Ueland, John Kjekshus, et al.. (2012). The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). American Heart Journal. 164(6). 878–883. 79 indexed citations
18.
Gullestad, Lars, Thor Ueland, John Kjekshus, et al.. (2012). Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal. 33(18). 2290–2296. 116 indexed citations
19.
Nymo, Ståle H., Thor Ueland, Erik T. Askevold, et al.. (2011). The association between neutrophil gelatinase‐associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*. Journal of Internal Medicine. 271(5). 436–443. 55 indexed citations
20.
Holm, Sverre, Thor Ueland, Tuva B. Dahl, et al.. (2011). Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke. PLoS ONE. 6(12). e28785–e28785. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026